{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T13:38:04Z","timestamp":1725889084088},"publisher-location":"Cham","reference-count":37,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319606989"},{"type":"electronic","value":"9783319606996"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-60699-6_77","type":"book-chapter","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T03:32:34Z","timestamp":1496719954000},"page":"799-817","source":"Crossref","is-referenced-by-count":0,"title":["Optimization of Combined Anticancer Treatment Using Models With Multiple Control Delays"],"prefix":"10.1007","author":[{"given":"Helmut","family":"Maurer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"\u015awierniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"key":"77_CR1","unstructured":"1. D. Hanahan, R.A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, 144 (2011), 647-670, 2011."},{"key":"77_CR2","doi-asserted-by":"crossref","unstructured":"2. J. Folkman, Anti-Angiogenesis: New Concept for Therapy of Solid Tumors, Annals of Surgery, 175, (1972), 409-416.","DOI":"10.1097\/00000658-197203000-00014"},{"key":"77_CR3","doi-asserted-by":"crossref","unstructured":"3. A.C. Billioux, U. Modlich, R, Bicknell, The Cancer Handbook: Angiogenesis, 2nd Edition, John Wiley & Sons, 2007.","DOI":"10.1002\/9780470025079.chap17.pub2"},{"key":"77_CR4","unstructured":"4. V.T. Devita, J.Folkman, Cancer: Principles and Practice of Oncology, 6th edition, Lippincott Williams & Wilkins Publishers, 2001."},{"key":"77_CR5","doi-asserted-by":"crossref","unstructured":"5. R.S. Kerbel, Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapies agent, BioEssays, 13 (1991), 31-36.","DOI":"10.1002\/bies.950130106"},{"key":"77_CR6","doi-asserted-by":"crossref","unstructured":"6. G. Bergers and D. Hanahan, Modes of resistance to antiangiogenic therapy, Nature Reviews Cancer, 8, (2008), 592-603.","DOI":"10.1038\/nrc2442"},{"key":"77_CR7","doi-asserted-by":"crossref","unstructured":"7. G. Gasparini, R. Longo, M. Fanelli, and B. A. Teicher, Combination of an- tiangiogenic therapy with other anticancer therapies: results, challenges, and open questions, Journal of Clinical Oncology, 23, (2005), 1295-1311.","DOI":"10.1200\/JCO.2005.10.022"},{"key":"77_CR8","doi-asserted-by":"crossref","unstructured":"8. L. S. Teng, K. T. Jin, K. F. He, H. H. Wang, J. Cao, and D. C. Yu, Advances in combination of antiangiogenic agents targeting VEGF-binding and conventional chemotherapy and radiation for cancer treatment, Journal of the Chinese Medical Association, 73, (2010), 281-288.","DOI":"10.1016\/S1726-4901(10)70062-9"},{"key":"77_CR9","doi-asserted-by":"crossref","unstructured":"9. J. Ma and D. J.Waxman, Combination of antiangiogenesis with chemotherapy for more effective cancer treatment, Molecular Cancer Therapeutics, 7, (2008), 3670-3684.","DOI":"10.1158\/1535-7163.MCT-08-0715"},{"key":"77_CR10","unstructured":"10. A. d\u2019Onofrio and A. Gandolfi, Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular \u201cpruning\u201d, Journal of Theoretical Biology, 264, (2010), 253-265."},{"key":"77_CR11","unstructured":"11. US National Institutes of Health, Clinical Trials, 2012, http:\/\/www.clinicaltrials.gov\/"},{"key":"77_CR12","unstructured":"12. M. Kimmel and A. Swierniak, Control Theory Approach to Cancer Chemotherapy: Benefiting from Phase Dependence and Overcoming Drug Resistance, Tutorials in Mathematical Biosciences III: Cell Cycle, Proliferation, and Cancer (A. Friedman- Ed.), Lecture Notes in Mathematics, Mathematical Biosciences Subseries, 1872, Springer, Heidelberg, (2006), 185-202"},{"key":"77_CR13","unstructured":"13. P. Hahnfeldt, D. Panigrahy, J. Folkman, and L. Hlatky, Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy, Cancer Research, 59, (1999), 4770-4775."},{"key":"77_CR14","unstructured":"14. A. Swierniak, Direct and indirect control of cancer populations, Bulletin of the Polish Academy of Sciences: Technical Sciences, 56, (2008), 367-378, 2008."},{"key":"77_CR15","doi-asserted-by":"crossref","unstructured":"15. A. d\u2019Onofrio and A. Gandolfi, Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999), Mathematical Biosciences, 191, (2004), 159-184.","DOI":"10.1016\/j.mbs.2004.06.003"},{"key":"77_CR16","doi-asserted-by":"crossref","unstructured":"16. A. Swierniak, Comparison of six models of antiangiogenic therapy, Applicationes Mathematicae, 36, (2009), 333-348.","DOI":"10.4064\/am36-3-6"},{"key":"77_CR17","doi-asserted-by":"crossref","unstructured":"17. A. Ergun, K. Camphausen, and L. M.Wein, Optimal scheduling of radiotherapy and angiogenic inhibitors, Bulletin of Mathematical Biology, 65, (2003), 407-424.","DOI":"10.1016\/S0092-8240(03)00006-5"},{"key":"77_CR18","doi-asserted-by":"crossref","unstructured":"18. M. Dolbniak, A. Swierniak, Comparison of simple models of periodic protocols for combined anticancer therapy, Computational and Mathematical Methods in Medicine, 2013, Article ID 567213, doi: 11.1055\/2013\/567213.","DOI":"10.1155\/2013\/567213"},{"key":"77_CR19","doi-asserted-by":"crossref","unstructured":"19. A. Swierniak, J. Klamka, Local controllability of models of combined anticancer therapy with delays in control, Math. Model. Nat. Phenom., 9, (2014), 216-226.","DOI":"10.1051\/mmnp\/20149413"},{"key":"77_CR20","doi-asserted-by":"crossref","unstructured":"20. R.K. Sachcs, L.R. Hlatky and P.Hahnfeldt, Simple ODE models of tumor growth and antoiangiogenic or radiation treatment, Math. Comput. Mod, 33, (1998), 1297-1304.","DOI":"10.1016\/S0895-7177(00)00316-2"},{"key":"77_CR21","doi-asserted-by":"crossref","unstructured":"21. U. Ledzewicz and H. Schaettler, Antiangiogenic therapy in cancer treatment as an optimal control problem, SIAM Journal on Control and Optimization, 46, (2007), 1052-1079.","DOI":"10.1137\/060665294"},{"key":"77_CR22","doi-asserted-by":"crossref","unstructured":"22. U. Ledzewicz and H. Schaettler, Analysis of optimal controls for a mathematical model of tumour anti-angiogenesis, Optimal Control Applications and Methods, 29, (2008), 41-57.","DOI":"10.1002\/oca.814"},{"key":"77_CR23","doi-asserted-by":"crossref","unstructured":"23. A. Swierniak, A. d\u2019Onofrio, and A.Gandolfi, Control problems related to tumor an- giogenesis, in: Proc. of the 32nd Annual Conference on IEEE Industrial Electronics (IECON 2006), Paris, 677-681, November 2006.","DOI":"10.1109\/IECON.2006.347815"},{"key":"77_CR24","doi-asserted-by":"crossref","unstructured":"24. U. Ledzewicz and H. Schaettler, On the optimality of singular controls for a class of mathematical models for tumor antiangiogenesis, Discrete and Continuous Dynamical Systems, Series B, 11, (2009), 691-715.","DOI":"10.3934\/dcdsb.2009.11.691"},{"key":"77_CR25","doi-asserted-by":"crossref","unstructured":"25. U. Ledzewicz and H. Schaettler, Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis, J. Theor. Biol., 252, (2008), 295-301.","DOI":"10.1016\/j.jtbi.2008.02.014"},{"key":"77_CR26","doi-asserted-by":"crossref","unstructured":"26. U. Ledzewicz, J. Marriott, H. Maurer, and H. Schaettler, Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment, Mathematical Medicine and Biology, 27, (2010), 157-179.","DOI":"10.1093\/imammb\/dqp012"},{"key":"77_CR27","doi-asserted-by":"crossref","unstructured":"27. U. Ledzewicz, H. Maurer, and H. Schaettler, Minimizing tumor volume for a math- ematical model of anti-angiogenesis with linear pharmacokinetics, in: Recent Advances in Optimization and its Applications in Engineering, pp. 267-276, Springer, 2010.","DOI":"10.1007\/978-3-642-12598-0_23"},{"key":"77_CR28","unstructured":"28. A. Swierniak, Modelling combined antiangiogenic and chemo-therapies, in: Proc. 14th National Conf. Appl. Math. Biol Medicine, Leszno, 2008, 127-133."},{"key":"77_CR29","doi-asserted-by":"crossref","unstructured":"29. A. d\u2019Onofrio, U. Ledzewicz, H. Maurer, and H. Schaettler, On optimal delivery of combination therapy for tumors, Math. Biosciences, 222, (2009), 13-26.","DOI":"10.1016\/j.mbs.2009.08.004"},{"key":"77_CR30","doi-asserted-by":"crossref","unstructured":"30. J. Klamka, H. Maurer, A. Swierniak, Local controllability and optima Control for a model of combined anticancer therapy with Control delays, Mathematical Biosciences and Engineering, 14, 1, (2016).","DOI":"10.3934\/mbe.2017013"},{"key":"77_CR31","unstructured":"31. R. Fourer, D.M. Gay and B.W. Kernighan, AMPL: A Modeling Language for Mathematical Programming, Duxbury Press, Brooks\u2013Cole Publishing Company, 1993."},{"key":"77_CR32","doi-asserted-by":"crossref","unstructured":"32. A. W\u00e4chter, and L.T. Biegler, On the implementation of an interior-point filter line-search algorithm for large-scale nonlinear programming, Mathematical Programming, 106 (2006), 25-57; cf. Ipopt home page (C. Laird and A. W\u00e4chter): https:\/\/projects.coin-or.org\/Ipopt","DOI":"10.1007\/s10107-004-0559-y"},{"key":"77_CR33","doi-asserted-by":"crossref","unstructured":"33. C. B\u00fcskens and H. Maurer, SQP methods for solving optimal control problems with control and state constraints : adjoint variables, sensitivity analysis and real time control, J. Comput. Appl. Math., 120, (2000), 85-99.","DOI":"10.1016\/S0377-0427(00)00305-8"},{"key":"77_CR34","doi-asserted-by":"crossref","unstructured":"34. H. Maurer, C. B\u00fcskens, J.H.R. Kim, and C.Y. Kaya, Optimization methods for the verification of second order sufficient conditions for bang-bang control, Optimal Control Appl. Meth., 26, (2005), 129-156.","DOI":"10.1002\/oca.756"},{"key":"77_CR35","doi-asserted-by":"crossref","unstructured":"35. U. Ledzewicz, H. Maurer, and H. Sch\u00e4ttler, Optimal and suboptimal protocols for a mathematical model for tumor antiangiogenesis in combination with chemotherapy, Mathematical Biosciences and Engineering, 8, (2011), 307-323.","DOI":"10.3934\/mbe.2011.8.307"},{"key":"77_CR36","doi-asserted-by":"crossref","unstructured":"36. L. G\u00f6llmann and H. Maurer, Theory and applications of optimal control problems with multiple time-delays, Special Issue on Computational Methods for Optimization and Control, J. of Industrial and Management Optimization, 10, No.2, (2014), 413-441.","DOI":"10.3934\/jimo.2014.10.413"},{"key":"77_CR37","unstructured":"37. US National Institutes of Health, Clinical Trials, (2014), http:\/\/www.clinicaltrials.gov"}],"container-title":["Advances in Intelligent Systems and Computing","Trends in Advanced Intelligent Control, Optimization and Automation"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-60699-6_77","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T13:07:24Z","timestamp":1569416844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-60699-6_77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319606989","9783319606996"],"references-count":37,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-60699-6_77","relation":{},"ISSN":["2194-5357","2194-5365"],"issn-type":[{"type":"print","value":"2194-5357"},{"type":"electronic","value":"2194-5365"}],"subject":[],"published":{"date-parts":[[2017]]}}}